• Matthew J Allsop, Lucy E Ziegler, Matthew R Mulvey, Sarah Russell, Ros Taylor, and Michael I Bennett.
• 1 St Gemma's Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
• Palliat Med. 2018 Sep 1; 32 (8): 1322-1333.

BackgroundUnderstanding service provision for patients with advanced disease is a research priority, with a need to identify barriers that limit widespread integration of palliative care.AimTo identify patient and organisational factors that influence the duration of hospice-based palliative care in the United Kingdom prior to death.DesignThis is a retrospective cohort study.Setting/ParticipantsA total of 64 UK hospices providing specialist palliative care inpatient beds and community services extracted data for all adult decedents (aged over 17 years) with progressive, advanced disease, with a prior referral (e.g. inpatient, community teams, and outpatient) who died between 1 January 2015 and 31 December 2015. Data were requested for factors relating to both the patient and hospice site.ResultsAcross 42,758 decedents, the median time from referral to death was 48 days. Significant differences in referral to death days were found for those with cancer (53 days) and non-cancer (27 days) ( p < 0.0001). As age increases, the median days from referral to death decreases: for those under 50 years (78 days), 50-74 years (59 days), and 75 years and over (39 days) ( p = 0.0001). An adjusted multivariable negative binomial model demonstrated increasing age persisting as a significant predictor of fewer days of hospice care, as did being male, having a missing ethnicity classification and having a non-cancer diagnosis ( p < 0.001).ConclusionDespite increasing rhetoric around early referral, patients with advanced disease are receiving referrals to hospice specialist palliative care very late in their illness trajectory. Age and diagnosis persist as determinants of duration of hospice specialist palliative care before death.

25 keywords...

hide…